LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2 and 5-HT7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
Source: Wikipedia "LY-215840" · CC BY-SA 4.0
Share this article: X · Bluesky